In all patients the percentage of activated lymphocytes with surface expression of IL12Rb1 was <1% indicating that it is an effective method for the screening of these patients. Three recurrent mutations were responsible for 85% of our families. Prognosis was good in patients, in whom specific antimicrobial therapy was given before dissemination occurs, as well as prophylactic antimicrobial treatment when needed and IFN-γ therapy for severe infectious episodes.
Mendelian susceptibility to mycobacterial disease (MSMD), which is one of the disorders of Innate Immunity, is a rare disorder in which the patients are susceptible to severe diseases with weakly virulent mycobacteria, s u c h a s Mycobacterium bovis i n B a c i l l e Calmette-Guerin (BCG) and environmental mycobacteria (EM), also known as atypical or nontuberculous mycobacteria in otherwise healthy individuals 1,2 . These patients are also susceptible to Salmonella, Candida and M. tuberculosis species 2,3 . Nine disease-causing genes have been described, including three genes controlling the response to IFN-γ (IFNGR1, IFNGR2, STAT1), four involved in IFN-γ production (IL12B, IL12RB1, NEMO, ISG15) , one involved in the IFN-γ dependent induction of IL-12 (IRF8) and another gene controlling the macrophage respiratory burst, which can be triggered by IFN-γ (CYBB) 2, [4] [5] [6] [7] [8] . The considerable allelic heterogeneity at some of these loci has resulted in the definition of up to 18 different inborn errors of immunity 2 . However, the genetic etiology of about half the cases of MSMD has not been identified yet 2 .
IL-12Rb1 deficiency is the most common form of MSMD 2 . IL-12Rb1 is a common receptor chain of the IL-12 and the IL-23 receptors and deficiency of IL-12Rb1 causes a profound defect in both IL-12 and IL-23 signaling 2, 7, 8, 9 . IL-12 is an important cytokine for the development of IFN-γ producing T cells and also induces IFN-γ production by Natural killer (NK) and Natural Killer T (NKT) cells 9 . The lack of IL-12 stimuli impairs the production of IFN-γ 2 . In IL-12Rb1 deficient patients the development of IL-17 producing T cells (Th17 cells) was also found to be impaired 10 Table I .
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In this study, we present the clinical features and genetic characteristics of 18 patients with IL12Rb1 deficiency.
Material and Methods
The patients included in the study were diagnosed at and followed up at 
Results
All index cases were presented clinically either with BCG or salmonella infections. The first clinical infection occurred at ages 2 months to 6 years. All 14 patients except one who were BCG vaccinated developed BCG infection (Table I) .
BCG infection (draining lymphadenitis developed after BCG vaccine or systemic or disseminated BCG infection) was present in 14, isolated salmonellosis in 3 patients, a combination of BCG and salmonella infections in 2, Salmonella and recurrent Leishmania infections in 1 patient.
Three patients presented with salmonella infection, another two patients had concomitant salmonella infection. One patient who was not BCG vaccinated presented with HenochSchonlein purpura (HSP) and dramatic and abrupt improvement was observed with antibiotics against salmonella, another patient developed leukocytoclastic vasculitis during follow up. Candidiasis was the accompanying feature in five patients. One patient experienced recurrent leishmaniasis along with salmonellosis. The follow up period was between 3 to 21 years (8 families reported earlier, Table I ). Patients were given prolonged specific antimicrobial agents, prophylaxis when needed and IFN-γ particularly during severe infectious episodes. Four patients died of BCG infections who had advanced or disseminated mycobacterial infection when first admitted. The percentage of lymphocytes with surface IL12Rb1 expression was found to be less than %1 in all patients (Fig 1) .
Fourteen families had 5 different homozygous mutations, the most common mutation was c.523C>T (p.R175W) (in 6 families) followed by 783+1G>A (R173P) (in 4 families) and 64+2T>G (in 2 families). One family each had c.592T>C and c.518G>C mutations (Fig.  2) , (Table I) .
Discussion
Mendelian susceptibility to mycobacterial diseases (MSMD), which is one of the disorders of Innate Immunity, is a rare immunodeficiency syndrome characterized by a narrow vulnerability to poorly virulent mycobacteria, such as BCG and EM 1,2 . These patients are also susceptible to salmonella, candida and M. tuberculosis species 2, 13, 14 . Some other intracellular microorganisms have been reported in a small number of patients 13 .
Thus the infectious phenotype extends beyond susceptibility to mycobacterial diseases.
IFN-γR1 deficiency is the first genetic defect identified in these patients while the most common genetic etiology of MSMD is IL-12Rb1 deficiency 2,4,13 .
This study consists of 18 patients with IL12Rb1 deficiency. Fourteen patients out of 15 who were BCG vaccinated presented with BCG infection. The most common and earliest infection occurred was BCG infection probably because of the early encounter with these microorganisms 13 . Three patients presented with salmonella infections, another two were an associated infection. Five patients had associated candidiasis and one patient experienced recurrent leishmaniasis. None of our patients developed infection with M. tuberculosis.
One patient first presented with leukocytoclastic vasculitis and responded dramatically to antibiotic treatment against salmonella, another case of leukocytoclastic vasculitis was observed during follow up period. Vasculitic skin involvement has been reported previously in patients with MSMD 13 . Three patients with IL-12/IL-23 deficiency out of 141 patients (2.1%) developed vasculitic skin lesions and was considered to be caused by antigenic overload or a defect in immune complex clearance 13 .
Candidiasis was observed as an associated feature in 5 (28%) patients. In the literature, mucocutaneous candidiasis has been reported in 32 of 132 (25%) symptomatic IL-12Rb1 Infections with some other intracellular pathogens (nocardia, klebsiella, histoplasma, paracoccidiomycose, coccidioides, toxoplasma, listeria) have been described mostly in single cases 13 . One of our patients experienced recurrent leishmaniasis 16 . He responded well to lyposomal amphotericin B treatment, however since he showed recurrences after the cessation of therapy he was given prophylactic Amp B on which he did well for the last 9 years.
The patients were followed-up up to 21 years. The prognosis was poor only in patients admitted at later stages of BCG infection. Four of our patients who were admitted with and died of disseminated BCG infection were diagnosed during the 1990s when the awareness of the disease was poor.
Three mutations were recurrent and covered 12 out of 15 families (85%). In 27 Turkish families reported in Beaucoudrey's 13 study, these 3 mutations covered 48% of the Turkish families.
The results of our patients showed that the analysis of the surface expression of IL-12Rb1 on activated lymphocytes in patients with features suggestive for this defect (e.g. patients with BCG infection, recurrent salmonella infections) and in family members is an effective method for screening of this entity. However, to prevent missing novel mutations which are associated with intact IL-12Rb1 expression, it may be advisable to measure IFN-γ production by activated T cells 7 . Other genetic etiologies for MSMD should also be searched. Among our patients IL-12Rb1 is the most common etiology of MSMD, up until now only two IFN-γR1 and one Interferon Stimulating Gene 15 (ISG15) deficiency were identified in our center 15 . Infectious phenotype of these genetic disorders continues to expand and it may be advisable to investigate patients with recurrent leishmaniasis and severe infections due to other infectious agents, although rarely described in these patients, for IL-12Rb1 deficiency.
